New State of the Art Manufacturing Facility will Help Meet Growing Demand for Continuous Glucose Monitoring Technology
Author Archive: AZBio
BioAccel Announces Competiton Categories for 2016 Solution’s Challenge
BioAccel, an organization dedicated to supporting early-stage medical device and technology entrepreneurs, announced competition categories for its premiere event, The Solutions Challenge, scheduled for Thursday, December 1, 2016.Continue reading
Solera Health Secures $4 Million in Series A1 Funding
Investors Include BlueCross BlueShield Venture Partners, Sandbox Industries and SJF VenturesContinue reading
Boosting Immunity in Older Adults: UA Health Sciences Immunologists Unmask New Infection-Fighting T Cells
Immune-system frailty in adults 65 and older is a widespread public health issue. A study led by the Department of Immunobiology at the University of Arizona College of Medicine – Tucson points to new cells that may hold a solution.Continue reading
What Happens When We Activate The Arizona Collaborative Gene
Arizona heats things up at BIO 2016
Continue reading
Arizona Biotech Industry Report Card Released at BIO 2016
The Biotechnology Innovation Organization (BIO) has released the Industry Report Cards for all 50 states today at the BIO International Convention
Arizona holds its position at Tier II in number of biotech firms and Tier III in biotech employment
Investments in research and development (R&D) and programs encouraging private investments in Arizona innovator companies is the state’s greatest opportunity for driving future high-wage job growth in the life science sector.Continue reading
National Bioscience Report Shows Industry Creating Jobs and Driving Innovation
Bioscience industry contributing to U.S. economic growth and improving quality of life for patientsContinue reading
Castle Biosciences Announces Clinical Results of Melanoma Gene Expression Test in 334-Patient Performance Cohort Study at ASCO 2016
Results confirm accuracy of DecisionDx-Melanoma to identify recurrence risk; A second independent, prospective study confirms test accuracy
BIO survey to support PDUFA 6 negotiations
Please take a few minutes to log in to BIO’s FDA survey and provide feedback on your company’s interactions with FDA.Continue reading
C-Path and CDISC Announce Updated Therapeutic Area Standard for TB
The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the open availability of an updated CDISC Therapeutic Area (TA) Standard for tuberculosis (TB). The tuberculosis v2.0 standard is an updated version of the original TB v1.0 standard and includes new content focused on pediatrics and drug susceptibility testing.Continue reading